Publication date: May 16, 2019 Dopamine dysregulation syndrome is a rare complication of Parkinson’s disease (PD) treatment. We present a 70-year-old woman with a long-standing PD and a clinical picture ... Read more

Publication date: May 16, 2019 The accumulation of misfolded proteins is a common pathological feature of many neurodegenerative disorders, including synucleinopathies such as Parkinson’s disease which is characterized by the ... Read more

Publication date: May 16, 2019 Nurr1, a nuclear receptor essential for the development, maintenance, and survival of midbrain dopaminergic neurons, is a potential therapeutic target for Parkinson’s disease, a neurological ... Read more

Publication date: May 10, 2019 Parkinson’s disease (PD) is the debilitating movement disorder, distinguished by dopaminergic and norepinephrinergic neurodegeneration. Apart from candidate gene mutations, several modifier loci have been reported ... Read more

Publication date: Feb 05, 2019 Motor but also non-motor effects are modulated by dopamine (DA) in Parkinson’s disease (PD). Impaired inhibition has been related to dopamine overdosing of the associative ... Read more